Back to search

Article

Molecular basis for activation of lecithin:cholesterol acyltransferase by a compound that increases HDL cholesterol

2018-09-20

Abstract excerpt

<h4>ABSTRACT</h4> Lecithin:cholesterol acyltransferase (LCAT) and LCAT-activating small molecules are being investigated as treatments for coronary heart disease (CHD) and familial LCAT deficiency (FLD). Herein we report the crystal structure of LCAT bound to a potent activator and an acyl intermediate-like inhibitor, thereby revealing an active conformation of LCAT and that the activator is bound exclusively to...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
ee46295f-5f88-53e0-8b45-f8303a72f631
DOI
10.1101/422725
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Molecular basis for activation of lecithin:cholesterol acyltransferase by a compound that increases HDL cholesterolDOI 10.1101/422725
Select a neighboring publication to make it the new centre.